🇺🇸 FDA

Drug profile · INN

ofloxacin

OFLOXACIN

approved
US status
approved
Patents linked
2
News articles
0

Quick answer

ofloxacin (OFLOXACIN) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.

Key facts

INN ofloxacin
Brand OFLOXACIN
Route OPHTHALMIC
Formulation INJECTABLE
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 12097185

    Compositions comprising ciprofloxacin and celecoxib

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7629458

    Preparation of levofloxacin and hemihydrate thereof

    Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is ofloxacin?

ofloxacin (OFLOXACIN) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.

What is the brand name for ofloxacin?

OFLOXACIN is a marketed brand name for ofloxacin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ofloxacin?

ofloxacin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.